title: Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development.
abstract: Bone Morphogenetic Protein 2 (BMP-2) and Osteogenic Protein 1 (OP-1, also termed BMP-7) are members of the transforming growth factor beta superfamily. In the present study, we have analyzed the effects of administering them locally at different stages and locations of the chick limb bud using heparin beads as carriers. Our results show that these BMPs are potent apoptotic signals for the undifferentiated limb mesoderm but not for the ectoderm or the differentiating chondrogenic cells. In addition, they promote intense radial growth of the differentiating cartilages and disturb the formation of joints accompanied by alterations in the pattern of Indian hedgehog and ck-erg expression. Interestingly, the effects of these two BMPs on joint formation were found to be different. While the predominant effect of BMP-2 is alteration in joint shape, OP-1 is a potent inhibitory factor for joint formation. In situ hybridizations to check whether this finding was indicative of specific roles for these BMPs in the formation of joints revealed a distinct and complementary pattern of expression of these genes during the formation of the skeleton of the digits. While Op-1 exhibited an intense expression in the perichondrium of the developing cartilages with characteristic interruptions in the zones of joint formation, Bmp-2 expression was a positive marker for the articular interspaces. These data suggest that, in addition to the proposed role for BMP-2 and OP-1 in the establishment of the anteroposterior axis of the limb, they may also play direct roles in limb morphogenesis: (i) in regulating the amount and spatial distribution of the undifferentiated prechondrogenic mesenchyme and (ii) in controlling the location of the joints and the diaphyses of the cartilaginous primordia of the long bones once the chondrogenic aggregates are established.
authors.affiliation: Departamento de Ciencias Morfológicas, Universidad de Extremadura, Badajoz, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Macias
authors.forename: Y
authors.initials: Y
authors.lastname: Gañan
authors.forename: T K
authors.initials: TK
authors.lastname: Sampath
authors.forename: M E
authors.initials: ME
authors.lastname: Piedra
authors.forename: M A
authors.initials: MA
authors.lastname: Ros
authors.forename: J M
authors.initials: JM
authors.lastname: Hurle
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000096:biosynthesis* / Q000494:pharmacology*; D002356:Cartilage / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D002642:Chick Embryo; D018507:Gene Expression Regulation, Developmental; D006811:Humerus; D017403:In Situ Hybridization; D007596:Joints / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D018878:Limb Buds / Q000502:physiology; D008648:Mesoderm / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D010012:Osteogenesis / Q000187:drug effects; D011884:Radius; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014457:Ulna
chemical_list: D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D016212:Transforming Growth Factor beta